Encompass Health (NYSE:EHC) Given New $150.00 Price Target at UBS Group

Encompass Health (NYSE:EHC) had its target price raised by UBS Group from $140.00 to $150.00 in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. They currently have a buy rating on the stock.

Several other research analysts have also commented on the company. Wall Street Zen lowered Encompass Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 6th. Stephens upgraded Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 price target for the company in a research report on Thursday, June 5th. Bank of America lifted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Wednesday, September 10th. KeyCorp lifted their price target on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Finally, Truist Financial lifted their price target on Encompass Health from $135.00 to $140.00 and gave the stock a “buy” rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $139.86.

Encompass Health Trading Down 0.8%

Shares of EHC stock opened at $123.58 on Thursday. Encompass Health has a 12-month low of $87.85 and a 12-month high of $127.86. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76. The stock’s 50-day moving average price is $120.94 and its 200-day moving average price is $115.37. The stock has a market capitalization of $12.45 billion, a price-to-earnings ratio of 24.18, a price-to-earnings-growth ratio of 2.18 and a beta of 0.93.

Encompass Health (NYSE:EHC) last issued its earnings results on Monday, August 4th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.20. The firm had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The business’s revenue was up 12.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Equities research analysts predict that Encompass Health will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.17. This represents a $0.76 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend is Wednesday, October 1st. Encompass Health’s payout ratio is presently 14.87%.

Insider Buying and Selling at Encompass Health

In other news, EVP Patrick William Tuer sold 1,020 shares of Encompass Health stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the sale, the executive vice president owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Encompass Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. EP Wealth Advisors LLC raised its stake in shares of Encompass Health by 2.4% during the second quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after acquiring an additional 88 shares in the last quarter. Pinnacle Wealth Planning Services Inc. raised its stake in shares of Encompass Health by 4.0% during the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after acquiring an additional 99 shares in the last quarter. Securian Asset Management Inc. raised its stake in shares of Encompass Health by 1.3% during the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after acquiring an additional 100 shares in the last quarter. State of Michigan Retirement System raised its stake in Encompass Health by 0.4% in the second quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock worth $2,973,000 after buying an additional 100 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd raised its stake in Encompass Health by 19.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after buying an additional 115 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.